ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » West Virginia » Pulmonary Disease

Top Pulmonary Disease Prescribers in West Virginia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
VISHNU PATEL MD

Pulmonary Disease

13,384

$1.06M

860
447 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 60%

$79
Average prescription price

Avg: $132

MAHESH SHROFF MD

Pulmonary Disease

10,713

$495K

262
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

17%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 60%

$46
Average prescription price

Avg: $132

SHRIKANT BEMBALKAR M.D.

Pulmonary Disease

8,760

$637K

305
236 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 60%

$73
Average prescription price

Avg: $132

RICHARD DURHAM MD

Pulmonary Disease

6,867

$500K

447
311 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 60%

$73
Average prescription price

Avg: $132

MARIA BOUSTANI MD

Pulmonary Disease

5,798

$715K

390
257 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 60%

$123
Average prescription price

Avg: $132

CHARLES PORTERFIELD DO

Pulmonary Disease

5,111

$548K

399
259 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 60%

$107
Average prescription price

Avg: $132

BHAILAL GONDALIA M.D.

Pulmonary Disease

4,940

$522K

465
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 60%

$106
Average prescription price

Avg: $132

ZAINAB SHAMMA-OTHMAN MD

Pulmonary Disease

4,606

$324K

252
190 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 60%

$70
Average prescription price

Avg: $132

WILLIAM POWERS DO

Pulmonary Disease

4,482

$285K

219
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

40%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 60%

$64
Average prescription price

Avg: $132

SALAM RAJJOUB MD

Pulmonary Disease

4,461

$447K

426
229 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 60%

$100
Average prescription price

Avg: $132

RONALD MUDRY MD

Pulmonary Disease

3,510

$550K

410
270 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 60%

$157
Average prescription price

Avg: $132

ROBERT ALTMEYER MD

Pulmonary Disease

3,284

$582K

434
381 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

74%
prescriptions for brand name drugs

Avg: 60%

$177
Average prescription price

Avg: $132

MELVIN SALUDES M.D.

Pulmonary Disease

2,955

$516K

500
361 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

74%
prescriptions for brand name drugs

Avg: 60%

$174
Average prescription price

Avg: $132

STEVEN MAXWELL D.O

Pulmonary Disease

2,932

$683K

260
218 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 60%

$233
Average prescription price

Avg: $132

FADI ALKHANKAN MD

Pulmonary Disease

2,461

$396K

228
135 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 60%

$161
Average prescription price

Avg: $132

PETER OTTAVIANO DO

Pulmonary Disease

2,410

$514K

263
179 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 60%

$213
Average prescription price

Avg: $132

BRIJINDER KOCHHAR MD

Pulmonary Disease

2,317

$361K

390
300 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 60%

$156
Average prescription price

Avg: $132

PRASAD DEVABHAKTUNI M.D.

Pulmonary Disease

2,073

$412K

316
245 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 60%

$199
Average prescription price

Avg: $132

ATTILA LENKEY MD

Pulmonary Disease

2,052

$539K

331
231 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 60%

$263
Average prescription price

Avg: $132

GEORGE ZALDIVAR M.D

Pulmonary Disease

1,925

$239K

177
129 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 60%

$124
Average prescription price

Avg: $132

JAMIL AHMED MD

Pulmonary Disease

1,845

$337K

298
229 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

76%
prescriptions for brand name drugs

Avg: 60%

$183
Average prescription price

Avg: $132

MALLINATH KAYI M.D.

Pulmonary Disease

1,710

$228K

225
145 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 60%

$133
Average prescription price

Avg: $132

RAMZI HADDADIN M.D.

Pulmonary Disease

1,626

$572K

255
168 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 60%

$352
Average prescription price

Avg: $132

ANDRZEJ JAWORSKI M.D

Pulmonary Disease

1,592

$218K

219
187 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 60%

$137
Average prescription price

Avg: $132

IMRAN KHAWAJA MD

Pulmonary Disease

1,547

$468K

221
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 60%

$302
Average prescription price

Avg: $132

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank